UroGen Pharma (URGN) Invested Capital (2021 - 2026)
Powered by 
Analysis
UroGen Pharma (URGN) Invested Capital (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 33.70 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7.35 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 6.25 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.13 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.30 Bn |
| 10 | UroGen Pharma | 2.23 Bn | 2.12 Bn | 65.88 Mn | 56.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56.34 Mn |
| Mar 31, 2026 | 65.28 Mn |
| Dec 31, 2025 | 16.74 Mn |
| Sep 30, 2025 | 6.70 Mn |
| Jun 30, 2025 | 29.13 Mn |
| Mar 31, 2025 | 75.65 Mn |
| Dec 31, 2024 | 112.93 Mn |
| Sep 30, 2024 | 147.22 Mn |
| Jun 30, 2024 | 128.13 Mn |
| Mar 31, 2024 | 57.46 Mn |
| Dec 31, 2023 | 33.34 Mn |
| Sep 30, 2023 | 198.52 Mn |
| Jun 30, 2023 | -40.14 Mn |
| Mar 31, 2023 | -18.61 Mn |
| Dec 31, 2022 | 8.18 Mn |
| Sep 30, 2022 | 8.58 Mn |
| Jun 30, 2022 | 30.28 Mn |
| Mar 31, 2022 | 53.72 Mn |
| Dec 31, 2021 | 8.41 Mn |